Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 3 5Phase 2 4Phase 1/2 2

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 1

Conditions

Breast Neoplasms 2Neoplasm Metastasis 1Advanced Breast Cancer 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interventional × AZD9833 × Clear all
NCT07195227 2026-05-29

CADILLAC

MedSIR

Phase 2 Recruiting
150 enrolled
Breast

Breast Neoplasms

NCT07427394 2026-05-28

SERENA-1b

AstraZeneca

Phase 2 Recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT04214288 2025-11-20

SERENA-2

AstraZeneca

Phase 2 Active not recruiting
240 enrolled 16 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT04588298 2025-01-24

SERENA-3

AstraZeneca

Phase 2 Completed
135 enrolled 17 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡